{
    "pmcid": "11319189",
    "qa_pairs": {
        "How does AlphaFold-Multimer contribute to the design of nanobodies against SARS-CoV-2?": [
            "By predicting the interaction between nanobodies and the SARS-CoV-2 spike protein",
            "By generating novel nanobody sequences from scratch",
            "By synthesizing nanobodies in vitro for experimental testing",
            "By directly measuring the binding affinity of nanobodies to the spike protein"
        ],
        "What is the primary focus of AlphaFold-Multimer as described in the paper?": [
            "Predicting the structures of multi-chain protein complexes",
            "Developing new algorithms for single-chain protein folding",
            "Enhancing the speed of protein sequence alignment",
            "Improving the resolution of cryo-electron microscopy images"
        ],
        "What potential does AlphaFold-Multimer have in the field of therapeutic development according to the paper?": [
            "Designing nanobody binders for the SARS-CoV-2 spike protein",
            "Creating vaccines for a wide range of viral infections",
            "Developing small molecule drugs for cancer treatment",
            "Engineering enzymes for industrial applications"
        ],
        "What specific challenge does AlphaFold-Multimer face in predicting nanobody structures?": [
            "Accurately predicting highly variable and conformationally diverse regions like the CDR-H3 loop",
            "Simulating the entire folding process of nanobodies in real-time",
            "Generating high-resolution images of nanobody structures",
            "Predicting the exact amino acid sequence of nanobodies"
        ],
        "Why is the integration of AlphaFold-Multimer predictions with experimental data important?": [
            "To validate and refine the predicted structures for therapeutic applications",
            "To reduce the computational cost of simulations",
            "To eliminate the need for experimental validation altogether",
            "To automate the process of nanobody synthesis"
        ]
    }
}